The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Open accessAbstract
Opioids are mainly used to treat both acute and chronic pain. Several opioids are metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and methadone). Polymorphisms in CYP2D6 have been studied for an association with the clinical effect and safety of these drugs. Other genes that have been studied for their association with opioid clinical effect or adverse events include OPRM1 (mu receptor) and COMT (catechol‐O‐methyltransferase). This guideline updates and expands the 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and codeine therapy and includes a summation of the evidence describing the impact of CYP2D6, OPRM1, and COMT on opioid analgesia and adverse events. We provide therapeutic recommendations for the use of CYP2D6 genotype results for prescribing codeine and tramadol and describe the limited and/or weak data for CYP2D6 and hydrocodone, oxycodone, and methadone, and for OPRM1 and COMT for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
Gaedigk, A., Simon, S., Pearce, R., Bradford, L., Kennedy, M., & Leeder, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100406 · Cited by 779
Self-citationCodeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041888 · Cited by 702
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., & Leeder, S. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69255-6 · Cited by 684
Self-citationCrews, K. R., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Klein, T. E., Caudle, K. E., Haidar, C. E., Shen, D. D., Callaghan, J. T., Sadhasivam, S., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.254 · Cited by 680
Self-citationAllelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
Caudle, K. E., Sangkuhl, K., Whirl‐Carrillo, M., Swen, J. J., Haidar, C. E., Klein, T. E., Gammal, R. S., Relling, M. V., Scott, S. A., Hertz, D. L., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12692 · Cited by 536
Self-citationUniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Volpe, D. A., Tobin, G. A. M., Mellon, R. D., Katki, A. G., Parker, R. J., Colatsky, T., Kropp, T. J., & Verbois, S. L. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.12.007 · Cited by 446
Kirchheiner, J., Schmidt, H., Tzvetkov, M., Keulen, J.-T., Lötsch, J., Roots, I., & Brockmöller, J. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500406 · Cited by 439
LALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
Self-citationThe hypoalgesic effect of tramadol in relation to CYP2D6*
Poulsen, L., Arendt-Nielsen, L., Brøsen, K., & Sindrup, S. H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90211-8 · Cited by 386
Impact of CYP2D6 genotype on postoperative tramadol analgesia
Stamer, U. M., Lehnen, K., Höthker, F., Bayerer, B., Wolf, S., Hoeft, A., & Stuber, F. (2003) · Pain · doi:10.1016/s0304-3959(03)00212-4 · Cited by 333
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
Madadi, P., Ross, C., Hayden, M., Carleton, B., Gaedigk, A., Leeder, J., & Koren, G. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.157 · Cited by 308
Self-citationEckhardt, K., Li, S., Ammon, S., Schänzle, G., Mikus, G., & Eichelbaum, M. (1998) · Pain · doi:10.1016/s0304-3959(98)00021-9 · Cited by 258
Nofziger, C., Turner, A. J., Sangkuhl, K., Whirl‐Carrillo, M., Agúndez, J. A. G., Black, J. L., Dunnenberger, H. M., Ruano, G., Kennedy, M. A., Phillips, M. S., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1643 · Cited by 242
Self-citationConcentrations of Tramadol and O-desmethyltramadol Enantiomers in Different CYP2D6 Genotypes
Stamer, U. M., Musshoff, F., Kobilay, M., Madea, B., Hoeft, A., & Stuber, F. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100152 · Cited by 241
Desta, Z., El‐Boraie, A., Gong, L., Somogyi, A. A., Lauschke, V. M., Dandara, C., Klein, K., Miller, N. A., Klein, T. E., Tyndale, R. F., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2166 · Cited by 234
Self-citationDevelopment and use of active clinical decision support for preemptive pharmacogenomics
Bell, G. C., Crews, K. R., Wilkinson, M. R., Haidar, C. E., Hicks, J. K., Baker, D. K., Kornegay, N. M., Yang, W., Cross, S. J., Howard, S. C., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001993 · Cited by 208
Self-citationSamer, C., Daali, Y., Wagner, M., Hopfgartner, G., Eap, C., Rebsamen, M., Rossier, M., Hochstrasser, D., Dayer, P., & Desmeules, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00709.x · Cited by 201
Self-citationReview of Opioid Pharmacogenetics and Considerations for Pain Management
Owusu Obeng, A., Hamadeh, I., & Smith, M. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1986 · Cited by 171
Smith, D. M., Weitzel, K. W., Elsey, A. R., Langaee, T., Gong, Y., Wake, D. T., Duong, B. Q., Hagen, M., Harle, C. A., Mercado, E., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0431-8 · Cited by 158
Self-citationCannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041384 · Cited by 152
Willmann, S., Edginton, A. N., Coboeken, K., Ahr, G., & Lippert, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.151 · Cited by 142
Ray, R., Ruparel, K., Newberg, A. B., Wileyto, E. P., Loughead, J., Divgi, C. R., Blendy, J. A., Logan, J., Zubieta, J.-K., & Lerman, C. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018699108 · Cited by 140
Andreassen, T. N., Eftedal, I., Klepstad, P., Davies, A. N., Bjordal, K., Lundström, S., Kaasa, S., & Dale, O. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1093-5 · Cited by 116
Current Concepts in Methadone Metabolism and Transport
Kharasch, E. D. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.326 · Cited by 95
Self-citationPharmacogenetics for Safe Codeine Use in Sickle Cell Disease
Gammal, R. S., Crews, K. R., Haidar, C. E., Hoffman, J. M., Baker, D. K., Barker, P. J., Estepp, J. H., Pei, D., Broeckel, U., Wang, W. C., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-3479 · Cited by 91
Self-citationNear-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer
Elkalioubie, A., Allorge, D., Robriquet, L., et al. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1080-x · Cited by 88
Kaplan, H. L., Busto, U. E., Baylon, G. J., Cheung, S. W., Otton, S. V., Somer, G. R., & Sellers, E. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36599-1 · Cited by 86
Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch, J., Rohrbacher, M., Schmidt, H., Doehring, A., Brockmöller, J., & Geißlinger, G. (2009) · Pain · doi:10.1016/j.pain.2009.03.023 · Cited by 83
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002683 · Cited by 83
Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog.
Cone, E. J., Darwin, W. D., Gorodetzky, C. W., & TAN, T. (1978) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06378-0 · Cited by 78
Taqi, M. M., Faisal, M., & Zaman, H. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s198654 · Cited by 61
Brousseau, D. C., McCarver, D. G., Drendel, A. L., Divakaran, K., & Panepinto, J. A. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.049 · Cited by 59
The Role of Hydromorphone and OPRM1 in Postoperative Pain Relief with Hydrocodone
Jortani, S. A. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e227 · Cited by 55
Hydrocodone in postoperative personalized pain management: Pro-drug or drug?
Stauble, M. E., Moore, A. W., Langman, L. J., Boswell, M. V., Baumgartner, R., McGee, S., Metry, J. E., & Jortani, S. A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.11.015 · Cited by 53
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children
Rodieux, F., Vutskits, L., Posfay-Barbe, K. M., Habre, W., Piguet, V., Desmeules, J. A., & Samer, C. F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00148 · Cited by 53
Self-citationA Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications
Cicali, E. J., Smith, D. M., Duong, B. Q., Kovar, L., Cavallari, L. H., & Johnson, J. A. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1768 · Cited by 53
Self-citationKlimas, R., Witticke, D., Fallah, S. E., & Mikus, G. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.779669 · Cited by 49
Codeine‐related adverse drug reactions in children following tonsillectomy: A prospective study
Prows, C. A., Zhang, X., Huth, M. M., et al. (2013) · The Laryngoscope · doi:10.1002/lary.24455 · Cited by 43
Self-citationThe Implausibility of Neonatal Opioid Toxicity from Breastfeeding
Zipursky, J. S., & Juurlink, D. N. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1882 · Cited by 37
Safety Issues of Pharmacological Acute Pain Treatment in Children
Rodieux, F., Piguet, V., Desmeules, J. A., & Samer, C. F. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1358 · Cited by 11
Self-citation
Cited by
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02198 · Cited by 304
Metadata
- Authors
- Crews, K. R., Monte, A. A., Huddart, R., Caudle, K. E., Kharasch, E. D., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Callaghan, J. T., Samer, C. F., Klein, T. E., Haidar, C. E., Van Driest, S. L., Ruano, G., Sangkuhl, K., Cavallari, L. H., Müller, D. J., Prows, C. A., Nagy, M., Somogyi, A. A., & Skaar, T. C.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2021-02-09
- Volume
- 110
- Issue
- 4
- Pages
- 888-896
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W3114326816
- Cited by
- 434
- References
- 42
- FWCI
- 54.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.